At Its Launch, STAR Trial Inherits Baggage Of Its Predecessor, P-1 Tamoxifin Study
In Brief: Strohl Leads Oncology Nursing Society; ONS Seeks Nominees For Consumer Panel
STAR Begins: Critics of Trial Call For Including A Placebo Arm
In The States: Illinois, Virginia approve Legislation Mandating Coverage of Care In Cancer Clinical Trials
Maryland to Use $1B In Tobacco Funds For Cancer Research, Anti-Smoking Program
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
